Concepedia

Publication | Open Access

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

DOIFull Paper Access

194

Citations

14

References

2013

Year

Rajnish Mago, Giovanna Forero, William M. Greenberg, Carl Gommoll, Changzheng Chen
Clinical Drug Investigation

Abstract

No new or inconsistent safety/tolerability findings were discovered during longer-term evaluation.

References

YearCitations

Page 1